(Udaipur Kiran News): Shares of Shilpa Medicare climbed over 2% in Tuesday’s trade after the company received initial authorization from the European Medicines Agency (EMA) for its Rivaroxaban Orodispersible Films.
The stock was trading at ₹839.65, up 2.74%, compared to its previous close of ₹817.25 on the BSE. It opened at ₹823.00 and touched an intraday high of ₹858.10 and a low of ₹823.00. A total of 7,864 shares changed hands during the session. The company’s market capitalization currently stands at ₹8,211.01 crore.
In the past 52 weeks, Shilpa Medicare has traded between a high of ₹1,003.20 (16 June 2025) and a low of ₹530.50 (7 April 2025). Promoter holding is at 44.23%, while institutions and non-institutions hold 18.64% and 37.13% respectively.
EMA authorization details
The EMA nod covers Rivaroxaban 10 mg, 15 mg, and 20 mg Orodispersible Films, submitted as a hybrid application under the Centralized Procedure. The product is a generic version of Bayer AG’s Xarelto tablets and is bioequivalent to the reference medicine. It is also the only Rivaroxaban available in ODF form, aimed at improving patient comfort, particularly for geriatric use.
Rivaroxaban is an anticoagulant used to treat deep vein thrombosis and pulmonary embolism, prevent their recurrence, and reduce risks of heart attack, stroke, or cardiovascular death in adults. The European market for oral Rivaroxaban formulations is estimated at $2.5 billion.
The approval has been granted for manufacturing at Shilpa Medicare’s Unit VI facility in Dabaspet, Bengaluru, which is already approved by the USFDA, EMA, and UK’s MHRA. This is the facility’s third prescription oral mouth-dissolving film approval in Europe.
Shilpa Medicare is engaged in producing and exporting high-quality APIs, fine chemicals, intermediates, herbal products, and speciality chemicals, with a focus on international regulatory standards.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
